Sellas Life Correlations
SLS Stock | USD 1.29 0.01 0.77% |
The current 90-days correlation between Sellas Life Sciences and Innate Pharma is 0.23 (i.e., Modest diversification). The correlation of Sellas Life is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Sellas Life Correlation With Market
Average diversification
The correlation between Sellas Life Sciences and DJI is 0.11 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Sellas Life Sciences and DJI in the same portfolio, assuming nothing else is changed.
Sellas |
Moving together with Sellas Stock
Moving against Sellas Stock
0.37 | GILD | Gilead Sciences | PairCorr |
0.59 | MOLN | Molecular Partners | PairCorr |
0.48 | PCVX | Vaxcyte | PairCorr |
0.42 | NUVB | Nuvation Bio | PairCorr |
0.42 | REPL | Replimune Group Downward Rally | PairCorr |
0.45 | AMGN | Amgen Inc | PairCorr |
0.35 | ATNF | 180 Life Sciences | PairCorr |
0.34 | BPMC | Blueprint Medicines Corp | PairCorr |
Related Correlations Analysis
0.71 | 0.16 | 0.21 | -0.13 | IPHA | ||
0.71 | 0.02 | 0.6 | -0.41 | DYAI | ||
0.16 | 0.02 | 0.31 | 0.43 | SNGX | ||
0.21 | 0.6 | 0.31 | -0.34 | ATXI | ||
-0.13 | -0.41 | 0.43 | -0.34 | CYCN | ||
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Sellas Stock performing well and Sellas Life Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Sellas Life's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
IPHA | 3.30 | (0.31) | 0.00 | (0.24) | 0.00 | 7.96 | 19.28 | |||
DYAI | 3.67 | (0.75) | 0.00 | (0.53) | 0.00 | 7.04 | 18.65 | |||
SNGX | 10.96 | 1.70 | 0.21 | 3.72 | 7.09 | 12.16 | 286.16 | |||
ATXI | 3.29 | (0.56) | 0.00 | (0.55) | 0.00 | 9.12 | 29.27 | |||
CYCN | 7.34 | 0.45 | 0.06 | 0.34 | 7.37 | 17.98 | 80.38 |
Sellas Life Corporate Management
Barbara Esq | General VP | Profile | |
Stacy Yeung | Associate VP | Profile | |
Jrg Breitkopf | Head Operations | Profile | |
ScD MD | President, Founder | Profile | |
Barbara Wood | Gen VP | Profile | |
Andrew Elnatan | Chemistry, Affairs | Profile | |
Robert Francomano | Senior Officer | Profile |